Sam A (Korea) Performance

009300 Stock  KRW 17,310  240.00  1.37%   
The entity has a beta of 0.11, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Sam A's returns are expected to increase less than the market. However, during the bear market, the loss of holding Sam A is expected to be smaller as well. At this point, Sam A Pharm has a negative expected return of -0.45%. Please make sure to validate Sam A's coefficient of variation, jensen alpha, treynor ratio, as well as the relationship between the standard deviation and total risk alpha , to decide if Sam A Pharm performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sam A Pharm Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Total Cashflows From Investing Activities-19.8 B
  

Sam A Relative Risk vs. Return Landscape

If you would invest  2,285,000  in Sam A Pharm Co on August 31, 2024 and sell it today you would lose (554,000) from holding Sam A Pharm Co or give up 24.25% of portfolio value over 90 days. Sam A Pharm Co is generating negative expected returns and assumes 1.9715% volatility on return distribution over the 90 days horizon. Simply put, 17% of stocks are less volatile than Sam, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon Sam A is expected to under-perform the market. In addition to that, the company is 2.65 times more volatile than its market benchmark. It trades about -0.23 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.2 per unit of volatility.

Sam A Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Sam A's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Sam A Pharm Co, and traders can use it to determine the average amount a Sam A's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.2284

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns009300

Estimated Market Risk

 1.97
  actual daily
17
83% of assets are more volatile

Expected Return

 -0.45
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.23
  actual daily
0
Most of other assets perform better
Based on monthly moving average Sam A is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sam A by adding Sam A to a well-diversified portfolio.

Sam A Fundamentals Growth

Sam Stock prices reflect investors' perceptions of the future prospects and financial health of Sam A, and Sam A fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sam Stock performance.

About Sam A Performance

By analyzing Sam A's fundamental ratios, stakeholders can gain valuable insights into Sam A's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Sam A has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Sam A has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Co., Ltd operates as a pharmaceutical company in South Korea. Co., Ltd was founded in 1945 and is based in Seoul, South Korea. Sam A is traded on Korean Securities Dealers Automated Quotations in South Korea.

Things to note about Sam A Pharm performance evaluation

Checking the ongoing alerts about Sam A for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Sam A Pharm help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Sam A Pharm generated a negative expected return over the last 90 days
About 66.0% of the company shares are owned by insiders or employees
Evaluating Sam A's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Sam A's stock performance include:
  • Analyzing Sam A's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sam A's stock is overvalued or undervalued compared to its peers.
  • Examining Sam A's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Sam A's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sam A's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Sam A's stock. These opinions can provide insight into Sam A's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Sam A's stock performance is not an exact science, and many factors can impact Sam A's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Sam Stock analysis

When running Sam A's price analysis, check to measure Sam A's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sam A is operating at the current time. Most of Sam A's value examination focuses on studying past and present price action to predict the probability of Sam A's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sam A's price. Additionally, you may evaluate how the addition of Sam A to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Equity Valuation
Check real value of public entities based on technical and fundamental data
Stocks Directory
Find actively traded stocks across global markets